Show simple item record

dc.contributor.authorPhelan, Alexandra L
dc.contributor.authorEccleston-Turner, Mark
dc.contributor.authorRourke, Michelle
dc.contributor.authorMaleche, Allan
dc.contributor.authorWang, Chenguang
dc.date.accessioned2020-09-21T22:23:25Z
dc.date.available2020-09-21T22:23:25Z
dc.date.issued2020
dc.identifier.issn0140-6736
dc.identifier.doi10.1016/s0140-6736(20)31873-0
dc.identifier.urihttp://hdl.handle.net/10072/397262
dc.description.abstractLaw can serve as both an enabler and a barrier to global health, equity, and justice.1 The impact of legal determinants of health on the COVID-19 pandemic is evident where law is being used as a mechanism to enable or prevent global equitable access to COVID-19 vaccines. Barriers to equitable access are partly driven by vaccine nationalism2 with governments seeking to use law to secure priority access to future vaccines through Advance Purchase Agreements (APAs) with vaccine manufacturers. These bilateral legal agreements can be in a nation's interest, but given the uncertain success of individual COVID-19 vaccine candidates and the global spread of SARS-CoV-2, APAs are a gamble and erode collaboration between countries. Importantly, such bilateral legal agreements are likely to contribute to inequities and potentially extend the pandemic's time frame. By contrast, multilateral legal agreements could be the path back to global health security and justice by re-establishing norms of international solidarity, committing to global equitable vaccine access initiatives, and laying a foundation for a post-pandemic era built on multilateralism and cooperation.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofjournalThe Lancet
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchcode11
dc.titleLegal agreements: barriers and enablers to global equitable COVID-19 vaccine access
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationPhelan, AL; Eccleston-Turner, M; Rourke, M; Maleche, A; Wang, C, Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access, The Lancet, 2020
dcterms.licensehttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.date.updated2020-09-09T09:43:25Z
dc.description.versionAccepted Manuscript (AM)
gro.description.notepublicThis publication has been entered in Griffith Research Online as an advanced online version.
gro.rights.copyright© 2020 Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.
gro.hasfulltextFull Text
gro.griffith.authorRourke, Michelle F.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record